(E)-1-(4-(6-((5-(3-Methoxystyryl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)hex-5-yn-1-one

ID: ALA4642634

PubChem CID: 156016591

Max Phase: Preclinical

Molecular Formula: C27H30N6O2S

Molecular Weight: 502.64

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCCCC(=O)N1CCN(c2cc(Nc3ncc(/C=C/c4cccc(OC)c4)s3)nc(C)n2)CC1

Standard InChI:  InChI=1S/C27H30N6O2S/c1-4-5-6-10-26(34)33-15-13-32(14-16-33)25-18-24(29-20(2)30-25)31-27-28-19-23(36-27)12-11-21-8-7-9-22(17-21)35-3/h1,7-9,11-12,17-19H,5-6,10,13-16H2,2-3H3,(H,28,29,30,31)/b12-11+

Standard InChI Key:  CXUCSGMCTDBENO-VAWYXSNFSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   33.1056  -16.2512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1193  -15.4364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8388  -15.0404    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.8485  -14.2255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1533  -13.8008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4338  -14.1968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4136  -15.0175    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.7387  -13.7762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.7585  -12.9616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0533  -12.5289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3341  -12.9248    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3242  -13.7454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0246  -14.1692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6390  -12.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9248  -12.8972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2239  -12.4735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5098  -12.8665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8129  -12.4430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1137  -12.0224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6556  -11.6894    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.5626  -13.8284    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5799  -13.0136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9233  -12.5193    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   34.1949  -11.7493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0097  -11.7650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2467  -12.5435    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.7285  -11.0781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0765  -10.3387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6102   -9.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9624   -8.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4968   -8.2603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6815   -8.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3341   -9.0726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8018   -9.7401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5200   -9.1438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0513   -8.4743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  2  0
  3  4  1  0
  5  4  2  0
  6  5  1  0
  7  6  2  0
  2  7  1  0
  6  8  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 11 12  1  0
 13 12  1  0
  8 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  3  0
 14 20  2  0
 21  4  1  0
 22 21  1  0
 23 22  1  0
 23 24  1  0
 25 24  2  0
 26 25  1  0
 22 26  2  0
 27 24  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 33 35  1  0
 35 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4642634

    ---

Associated Targets(Human)

ABL1 Tclin Cereblon/BCR/ABL (220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 502.64Molecular Weight (Monoisotopic): 502.2151AlogP: 4.62#Rotatable Bonds: 9
Polar Surface Area: 83.48Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.83CX Basic pKa: 6.49CX LogP: 5.39CX LogD: 5.34
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.34Np Likeness Score: -1.52

References

1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y..  (2020)  Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects.,  63  (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967]

Source